Sevoflurane is used as an inhalational general anesthetic for the induction and maintenance of anesthesia; it exhibits anesthetic potency similar to enflurane and approximately half that of halothane, with a shorter induction time compared to enflurane and halothane, and a comparable recovery time; it is also used for its ability to inhibit the activation of inflammatory neutrophils and granulocytes in human blood during simulated extracorporeal circulation.